Leading Public

Digital Therapeutic Company

Dthera Sciences is working to improve the lives of seniors and individuals suffering from neurodegenerative diseases, as well as those who care for them.

About Us

Breaking News: DTHERA SCIENCES RECEIVES FDA BREAKTHROUGH DEVICE DESIGNATION FOR ITS ALZHEIMER’S FOCUSED DEVELOPMENT-STAGE PRODUCT “DTHR-ALZ”

Explainer Video

Dthera in the News

Dthera Sciences Launches ReminX – Dthera Sciences Appoints Dr. Amir Kalali to Board of Directors

Stock Information

Click Here